©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2014; 20(2): 414-424
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.414
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.414
Table 2 Summary of outcomes post orthotopic liver transplant in hepatitis B virus/human immunodeficiency virus co-infection
| Ref. | Study period | Country | n | Median follow-up (mo) | Survival | Graft survival | Comments |
| Coffin et al[49] | 2001-2007 | United States | 22 | 42 | 85% 1 yr | 85% 1 yr | About 50% had detectable HBV pre transplant |
| 85% 3 yr | 85% 3 yr | ||||||
| Tateo et al[97] | 1999-2007 | France | 13 | 32 | 100% | 100% | 1 co-infected with HDV, 2 with HCV, 4 with HCV and HDV |
| Anadol et al[96] | 1997-2011 | Germany | 10 | 611 | 90% 1 yr | NR | |
| 80% 5 yr | |||||||
| Schreibman et al[98] | 1999-2006 | United States | 8 | NR | 75% 1 yr | NR | 2 co-infected with HCV, 1 fulminant hepatic failure |
| 75% 3 yr | |||||||
| Norris et al[99] | 1995-2003 | United Kingdom | 4 | 22 | 100% 1 yr | NR |
- Citation: Congly SE, Doucette KE, Coffin CS. Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation. World J Gastroenterol 2014; 20(2): 414-424
- URL: https://www.wjgnet.com/1007-9327/full/v20/i2/414.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i2.414